文献速递物质与行为成瘾

高效力大麻使用与健康:观察性研究与实验性研究的系统综述

High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies.
PubMed 文献 · Am J Psychiatry · 2025-03-26

该系统综述检索五个生物医学数据库,从4545条记录中纳入42项观察性与实验性研究,评估高效力大麻使用与多种健康结局的关系。多数研究聚焦心理健康、「问题性」大麻使用及其他物质使用领域;「问题性」大麻使用领域的结果提示与高效力大麻使用存在关联,其他领域结果一致性较低但倾向于高效力使用结局更差,治疗性结局有限且混杂;总体证据确定性为「极低」。

要点

  • 「问题性」大麻使用领域的结果提示与高效力大麻使用存在关联。
  • 其他领域结果一致性较低,但倾向于高效力使用结局更差。
  • 总体证据确定性为「极低」,研究多为横断面设计。

核心结论

  • 「问题性」大麻使用领域的结果提示与高效力大麻使用存在关联。
  • 研究主要限于横断面研究且覆盖的不良健康领域较少,强调需要前瞻性研究探究治疗、心肺、癌症及围产期结局。
  • 在证据基础改善的同时,遏制高效力大麻使用的政策可能是有依据的。

研究设计与样本

  • 系统综述,检索五个生物医学研究数据库。
  • 从4545条筛选记录中纳入42项符合条件的研究。
  • 采用生态学相关的效力(THC百分比)暴露-比较类别:1%-9%、10%-19%、20%-30%、kief/resin(约30%-50%)、concentrates(≥60%)。
  • 以一份关于大麻与大麻素类的里程碑式科学报告确定结局纳入标准。
  • 两名评审员独立进行文章筛选与选择、数据提取及质量评估,采用定量(关联方向、二项检验)与叙述性方法合成结果,并通过GRADE框架确定证据确定性。

主要发现

  • 多数研究涉及心理健康、「问题性」大麻使用及其他物质使用领域的结局。
  • 「问题性」大麻使用领域的结果提示与更高效力大麻使用存在关联。
  • 其他领域结果一致性较低,但倾向于更高效力使用对应更差结局。
  • 治疗性结局有限且混杂。
  • 总体证据确定性为「极低」。

关键数值与推荐

  • 效力暴露-比较类别:1%-9%、10%-19%、20%-30%、kief/resin(约30%-50%)、concentrates(≥60%)。
  • 总体证据确定性按GRADE框架评定为「极低」。

临床怎么用

  • 原文未据此给出针对精神心理科临床实践的具体推荐。

局限性

  • 总体证据确定性为「极低」。
  • 研究主要限于横断面研究且覆盖的不良健康领域较少。
  • 治疗性结局有限且混杂。
  • 其他领域结果一致性较低。
  • 原文指出需要前瞻性研究探究治疗、心肺、癌症及围产期结局。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Amid continuously rising concentrations of delta-9-tetrahydrocannabinol (THC) in cannabis (i.e., potency), high-potency cannabis is a major topic in contemporary cannabis policy discussions, yet its impact on health is not well understood. The authors conducted a systematic review of observational and experimental studies examining the relationship between high-potency cannabis use and a range of health outcomes. METHODS: Records were obtained from a systematic search of five biomedical research databases. The authors developed ecologically relevant potency (percent THC) exposure-comparison categories (1%-9%, 10%-19%, 20%-30%, kief/resin [∼30%-50%], concentrates [≥60%]) and used a landmark scientific report on cannabis and cannabinoids to determine outcome eligibility. Two reviewers independently conducted article screening and selection, extraction, and quality assessment. Findings were synthesized using both quantitative (association direction, binomial test) and narrative approaches. Certainty in the evidence was determined via the Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) framework. RESULTS: Of 4,545 screened records, 42 were eligible. Most studies addressed outcomes in the mental health, "problem" cannabis use, and other substance use domains. Findings in the "problem" cannabis use domain were suggestive of an association with higher-potency cannabis use. Findings were less consistent in other domains but tended to favor poorer outcomes with higher-potency use. Therapeutic outcomes were limited and mixed. Overall, certainty in the evidence was "very low." CONCLUSIONS: Findings within the "problem" cannabis use domain were suggestive of an association with high-potency use. Research is largely limited to cross-sectional studies spanning few adverse health domains, underscoring the need for prospective studies probing therapeutic, cardiorespiratory, cancer, and pre- and perinatal outcomes. Policies to curb high-potency cannabis use may be warranted while the evidence base improves.

来源:Am J Psychiatry,查看原文。版权归原作者所有。

引用

  1. Lake S, Murray CH, Henry B, et al. High-Potency Cannabis Use and Health: A Systematic Review of Observational and Experimental Studies. Am J Psychiatry. 2025. PMID: 40134269. doi:10.1176/appi.ajp.20240269

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。